Breast screens for trans women stirs debate
Breast screening habits for transsexual women shouldn't differ from those of biological women, according to a recent European study.
Breast screening habits for transsexual women shouldn't differ from those of biological women, according to a recent European study. However, a human sexuality expert disagrees, saying screening for transsexual women should depend on when the patient started estrogen therapy and not age alone.
The researchers found mammography and breast sonography were technically feasible in the 50 women who received sex-reassignment surgery. No gross anomalies were detected. In addition, 98% of the patients intended to come back for screening (EJR 2010;74:
508-513).
The study recommended a normal screening regimen for transsexual women. The mean age of study subjects was 43 ± 10.5 years.
Not everyone agrees with the study's conclusions, however.
Screening mammography for transsexual women should start at age 50, provided they have had five years of hormone therapy, said Dr. Jamie Feldman, an associate professor in the human sexuality program at the University of Minnesota.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
